Puylaert Kevin has filed 4 insider transactions across 1 company since March 2026.
Most recent transaction: a grant/award of 56468 shares of SOPHiA GENETICS SA ($SOPH) on April 02, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | SOPHiA GENETICS SA | $SOPH | Puylaert Kevin | Chief Sales Officer | A | Ordinary Shares | 56468 | $0.00 | 56,468.0000 | 68,486,338 | 9999.99% | 0.08% |
| April 2, 2026 | SOPHiA GENETICS SA | $SOPH | Puylaert Kevin | Chief Sales Officer | A | Share Option (Right to Buy) | 82335 | $0.00 | 82,335.0000 | 68,486,338 | 9999.99% | 0.12% |
| March 31, 2026 | SOPHiA GENETICS SA | $SOPH | Puylaert Kevin | Chief Sales Officer | S | Ordinary Shares | 3 | $4.71 | 92,383.0000 | 68,486,338 | 0.00% | 0.00% |
| March 19, 2026 | SOPHiA GENETICS SA | $SOPH | Puylaert Kevin | Chief Sales Officer | S | Ordinary Shares | 33 | $4.76 | 92,386.0000 | 68,486,338 | 0.04% | 0.00% |